tirzepatide/semaglutide Tirzepatide Shows Superior Weight Loss Over Semaglutide in Phase 3 Trial Overview of Tirzepatide and Semaglutide

Rong X et al

Written by Taylor Woosley, Science Writer

Research indicates that glycaemic control can deteriorate relatively quickly after cessation, particularly if no alternative diabetes medication is introduced

But the long-term question is what happens after you reach your goal weight

Consequences include a hypercoagulable state that increases the risk of developing abnormal blood clots in veins, particularly the deep veins of the legs ( deep vein thrombosis ) and the lungs ( pulmonary embolism )

We opted for an 80% increase in stimulation based on the consensus reached in several experimental studies conducted on rats and mice [7,17,23]